Jouve Léa, Borderie Vincent, Sandali Otman, Temstet Cyrille, Basli Elena, Laroche Laurent, Bouheraoua Nacim
*Quinze-Vingts National Ophthalmology Hospital, UPMC-Sorbonne Universities, Paris, France; †INSERM UMR S 968, Institut de la Vision, Paris, France; ‡Sorbonne Universities, UPMC Univ Paris 06, UMR S 968, Institut de la Vision, Paris, France; and §CNRS, UMR 7210, Paris, France.
Cornea. 2017 Feb;36(2):153-162. doi: 10.1097/ICO.0000000000001062.
To compare the efficacy, safety, and microstructural corneal changes during 2 years after conventional corneal collagen cross-linking (C-CXL) and transepithelial corneal CXL by iontophoresis (I-CXL) for keratoconus.
Eighty eyes of 80 patients with progressive keratoconus were treated by C-CXL (n = 40) or I-CXL (n = 40). Patients were investigated before surgery and 1, 3, 6, 12, and 24 months after treatment. We measured central corneal thickness and maximal simulated keratometry values (Kmax) and performed specular microscopy and in vivo confocal microscopy at each time point. The demarcation line was assessed 1 month after treatment.
Kmax remained stable after I-CXL during the entire study period (P = 0.56), whereas the average keratometry increased by 0.2 diopter (50.9 ± 5.6-51.1 ± 5.2). Kmax significantly decreased 1 (P = 0.02) to 2 years (P < 0.01) after C-CXL, with an average decrease of 1.1 diopters (49.9 ± 4.5-48.8 ± 4.2). The failure rate of I-CXL was 20% and that of C-CXL 7.5%. The demarcation line was superficially visible in 35% of cases after I-CXL compared with 95% of cases after C-CXL. Endothelial cell density and central corneal thickness remained stable during the entire study period. The change in Kmax 2 years after C-CXL and I-CXL and the preoperative Kmax were negatively correlated (r = 0.14, P = 0.013, and r = 0.17, P = 0.007, respectively).
I-CXL halted progression of keratoconus less efficiently than did C-CXL after 2 years of follow-up. Longer prospective studies are still needed to ensure I-CXL efficacy.
比较传统角膜胶原交联术(C-CXL)和离子电渗法经上皮角膜交联术(I-CXL)治疗圆锥角膜2年后的疗效、安全性及角膜微观结构变化。
80例进展期圆锥角膜患者的80只眼接受了C-CXL(n = 40)或I-CXL(n = 40)治疗。在手术前以及治疗后1、3、6、12和24个月对患者进行检查。我们测量了中央角膜厚度和最大模拟角膜曲率值(Kmax),并在每个时间点进行了角膜内皮显微镜检查和活体共聚焦显微镜检查。在治疗后1个月评估分界线。
在整个研究期间,I-CXL后Kmax保持稳定(P = 0.56),而平均角膜曲率增加了0.2屈光度(50.9±5.6 - 51.1±5.2)。C-CXL后1年(P = 0.02)至2年(P < 0.01)Kmax显著降低,平均降低1.1屈光度(49.9±4.5 - 48.8±4.2)。I-CXL的失败率为20%,C-CXL为7.5%。I-CXL后35%的病例分界线表面可见,而C-CXL后为95%。在整个研究期间,内皮细胞密度和中央角膜厚度保持稳定。C-CXL和I-CXL后2年Kmax的变化与术前Kmax呈负相关(分别为r = 0.14,P = 0.013和r = 0.17,P = 0.007)。
随访2年后,I-CXL阻止圆锥角膜进展的效果不如C-CXL。仍需要更长时间的前瞻性研究来确保I-CXL的疗效。